RIBS (Drug Discovery) Overview

  • Year Founded
  • 2025

Year Founded

  • Status
  • Private

  • Employees
  • 10

Employees

  • Latest Deal Type
  • Seed

  • Investors
  • 1

RIBS (Drug Discovery) General Information

Description

Operator of a custom-made treatment company intended for aortic arch aneurysms. The company is currently operating in Stealth Mode.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 2-3-11 Nihonbashi Honcho
  • Tokyo, 103-0023
  • Japan
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Corporate Office
  • 2-3-11 Nihonbashi Honcho
  • Tokyo, 103-0023
  • Japan

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

RIBS (Drug Discovery) Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
1. Seed Round 01-Jan-2026 Completed Stealth
To view RIBS (Drug Discovery)’s complete valuation and funding history, request access »

RIBS (Drug Discovery) Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

RIBS (Drug Discovery) Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds
Diamond Medino Capital Venture Capital Minority
To view RIBS (Drug Discovery)’s complete investors history, request access »

RIBS (Drug Discovery) FAQs

  • When was RIBS (Drug Discovery) founded?

    RIBS (Drug Discovery) was founded in 2025.

  • Where is RIBS (Drug Discovery) headquartered?

    RIBS (Drug Discovery) is headquartered in Tokyo, Japan.

  • What is the size of RIBS (Drug Discovery)?

    RIBS (Drug Discovery) has 10 total employees.

  • What industry is RIBS (Drug Discovery) in?

    RIBS (Drug Discovery)’s primary industry is Drug Discovery.

  • Is RIBS (Drug Discovery) a private or public company?

    RIBS (Drug Discovery) is a Private company.

  • What is RIBS (Drug Discovery)’s current revenue?

    The current revenue for RIBS (Drug Discovery) is .

  • Who are RIBS (Drug Discovery)’s investors?

    Diamond Medino Capital has invested in RIBS (Drug Discovery).

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process